IPP Bureau
Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr
By IPP Bureau - November 03, 2023
Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023
Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr
By IPP Bureau - November 03, 2023
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
By IPP Bureau - November 02, 2023
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
Zydus acquires UK based LiqMeds Group
By IPP Bureau - November 02, 2023
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Aster DM Healthcare launches a 506-bed multi-specialty hospital in Bengaluru
By IPP Bureau - November 02, 2023
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
Sun Pharmaceutical Industries Q2 FY 24 consolidated PAT higher at Rs. 2375.51 Cr
By IPP Bureau - November 02, 2023
Sun Pharmaceutical Industries has reported total income of Rs. 12486.02 crores during the period ended September 30, 2023
NATCO Pharma announces successful completion of USFDA inspection
By IPP Bureau - November 02, 2023
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
Mankind Pharma Q2 FY24 consolidated PAT higher at Rs. 501.02 Cr
By IPP Bureau - November 01, 2023
Mankind Pharma has reported total income of Rs. 2768.07 crores during the period ended September 30, 2023
Thyrocare Technologies posts Q2 FY24 consolidated PAT at Rs. 20.34 Cr
By IPP Bureau - November 01, 2023
Thyrocare Technologies has reported total income of Rs. 150.17 crores during the period ended September 30, 2023
Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
By IPP Bureau - November 01, 2023
Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023
Lupin Mandideep plant gets USFDA green signal
By IPP Bureau - November 01, 2023
The inspection of the facility conducted from August 7 to August 11, 2023
Pfizer posts Q3 loss as Covid-19 revenues shrink
By IPP Bureau - November 01, 2023
Revenue in the three months ended on Oct. 1 also slipped by 42% to US$ 13.23 billion
Aragen setting up a US$ 30 million bio-manufacturing site in Bengaluru
By IPP Bureau - October 31, 2023
Biologics manufacturing to expand the Aragen platform by offering “gene to GMP” solution
Indian Health Minister Dr. Mandaviya addresses 76th session of the WHO Regional Committee for South-East Asia
By IPP Bureau - October 31, 2023
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
Sun Pharma to co-market Zydus’s CKD treatment drug ‘Desidustat’ in India
By IPP Bureau - October 31, 2023
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
